European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“Registrations and abstract submissions are now open for the EORTC-NCI-AACR (ENA) Molecular Targets and Cancer Therapeutics Symposium 2026.
Join a leading international platform bringing together experts in drug development, translational research and molecular target validation.
- Submit your abstract and share your latest research
- Connect with a global community of scientists, clinicians and industry leaders
Secure your spot and contribute to shaping the future of cancer research!”
Other articles about EORTC on OncoDaily.